#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyoderma gangrenosum Metastatic malignant melanoma Henoch-Schonlein purpura Alexander disease Neurofibromatosis Burkitt's lymphoma Heavy menstrual bleeding Cervix carcinoma Diabetes insipidus Nasopharyngeal cancer Rhabdoid tumour Hypertriglyceridaemia Central nervous system lymphoma Autoimmune hepatitis Oesophageal carcinoma More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Basic Information Angiosarcoma metastatic – Treatment Waldenstrom’s macroglobulinaemia – Life with Disease Hairy cell leukaemia – Basic Information Vascular malformation Sjogren’s syndrome – Trials in Disease Wiskott-Aldrich syndrome – Life with Disease Haemophilia B without inhibitors – Life with Disease Toxic epidermal necrolysis – Basic Information Haemophilia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cytarabine Calcium Folinate Pentahydrate Db-1303 Brimonidine Salbutamol Calcium Levofolinate Simvastatin Irbesartan Indapamide Ebastine Anhydrous Docetaxel Emiplacel Ripretinib Transpocart19 Pegvaliase Ponsegromab BW-20805 Propylene Glycol Mirtazapine Avb-101 More therapies…

    Learn about Your Condition

    BK virus infection Atrophic vulvovaginitis Herpes simplex reactivation Infertility Osteopenia Congenital myopathy Ovarian cancer stage III Neurodevelopmental disorder Hysterectomy Left ventricular dysfunction Extra-osseous Ewing's sarcoma Autoimmune hepatitis Bipolar I disorder Pancreatic neoplasm Cardiovascular disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CRS Clinical Research Services Management GmbH

CRS Clinical Research Services Management GmbH

Siemensdamm 65, Siemensstadt, Berlin, 13627, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

    Recruiting

    3 1
    Investigated Drugs:
    • Azd5004
    Germany Italy Poland Spain

  • A study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.

    Recruiting

    3 1
    Investigated Drugs:
    • LY3841136 SODIUM
    Belgium Germany Poland

  • Study of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial vaginosis
    Investigated Drugs:
    • Chlorhexidine Gluconate
    • Metronidazole
    Germany

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    • Deucravacitinib
    Germany Hungary Italy Poland Romania Spain

  • Effect of multiple doses of BI 1358894 on the pharmacokinetics of ethinylestradiol and drospirenone in healthy women

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • DROSPIRENONE
    • Ethinylestradiol
    Germany

  • Study of BI 1810631 oral bioavailability in healthy men under fed vs fasted conditions

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Zongertinib
    Germany

  • Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia Germany Poland Spain

  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Belgium Czechia Denmark Estonia Finland Germany +5

  • Study on the Effects of Leniolisib in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Activated PI3 kinase delta syndrome
    Investigated Drugs:
    • Leniolisib Phosphate
    Germany
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!